Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Monday, November 9, 2009, 8:50PM ET - U.S. Markets Closed. Dow Up 2.03% Nasdaq Up 1.97%
NovaBay Pharmaceuticals, Inc. (NBY)At 4:00PM ET: 2.14  Down 0.01 (0.47%)  
MORE ON NBY
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Fri, Oct 30, 2009
NovaBay's Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis
PR Newswire (Fri, Oct 30)
Wed, Oct 28, 2009
NovaBay to Hold Conference Call to Review Aganocide Data Presented at the Infectious Diseases Society of America Meeting
PR Newswire (Wed, Oct 28)
Thu, Oct 22, 2009
NovaBay Pharmaceuticals to Present at 8th Annual Bio Investor Forum 2009 in San Francisco
PR Newswire (Thu, Oct 22)
Mon, Oct 19, 2009
NovaBay hires chief scientific officer
at bizjournals.com (Mon, Oct 19)
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
PR Newswire (Mon, Oct 19)
Thu, Sep 24, 2009
NovaBay Pharmaceuticals to Present at Maxim Group Growth Conference
PR Newswire (Thu, Sep 24)
Mon, Sep 14, 2009
NovaBay(R) Presents Data Confirming Its Aganocide(R) Compounds Are Effective In Killing Bacteria That Have Developed Multidrug-Resistance
PR Newswire (Mon, Sep 14)
Thu, Sep 10, 2009
NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections
PR Newswire (Thu, Sep 10)
Fri, Sep 4, 2009
NOVABAY PHARMACEUTICALS, INC. Financials
EDGAR Online Financials (Fri, Sep 4)
Thu, Sep 3, 2009
NovaBay(R) Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference September 10, 2009 in New York City
PR Newswire (Thu, Sep 3)
Wed, Aug 26, 2009
NovaBay closes $2.45 million stock offering
AP (Wed, Aug 26)
NovaBay Pharmaceuticals Announces the Closing of Its $2.45 Million Registered Direct Offering of Common Stock and Warrants
Marketwire (Wed, Aug 26)
Mon, Aug 24, 2009
NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting
PR Newswire (Mon, Aug 24)
Fri, Aug 21, 2009
NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
EDGAR Online (Fri, Aug 21)
NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
PR Newswire (Fri, Aug 21)
NovaBay Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering of Common Stock and Warrants
Marketwire (Fri, Aug 21)
Fri, Aug 14, 2009
NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
PR Newswire (Fri, Aug 14)
NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 14)
Tue, Aug 4, 2009
NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q/A, Quarterly Report
EDGAR Online (Tue, Aug 4)
Mon, Aug 3, 2009
NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Aug 3)
Older Headlines - Download Recent Headlines
View headlines from:
Add NBY News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage